Abstract
We investigated the effects of soy protein and soy protein hydrolysate on blood pressure control, angiotensin-converting enzyme (ACE) activity, and renal function in a rat chronic renal failure model. Rats that had undergone a 5/6 nephrectomy were separated into three groups and fed different experimental diets for 14 weeks. At the end of the study, rats that fed a diet containing soy protein as the protein source had better blood pressure control and renal function, as well as lower circulating ACE activity and renal tumor-necrosis factor-α (TNF-α) concentration than rats fed a casein protein diet. Soy protein hydrolysate was shown to be as effective as soy protein in preventing the elevation of blood pressure, the progression of renal failure, and decreases in kidney TNF-α level, plasma ACE activity, and insulin concentration. In conclusion, the beneficial effects of consuming soy protein on blood pressure and renal function may be mediated mostly by its pepsin-digested hydrolysate through its ACE inhibitory activity.
Similar content being viewed by others
Article PDF
References
Bakris GL : Hypertension and nephropathy. Am J Med 2003; 115 ( Suppl 8A): 49S–54S.
Goldfarb DA, Novick AC : The renin-angiotensin system: revised concepts and implications for renal function. Urology 1994; 43: 572–583.
Fanti P, Asmis R, Stephenson TJ, Sawaya BP, Franke AA : Positive effect of dietary soy in ESRD patients with systemic inflammation—correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol Dial Transplant 2006; 21: 2239–2246.
Taniguchi M, Kim S, Zhan Y, Iwao H : Role of intrarenal angiotensin-converting enzyme in nephropathy of type II diabetic rats. Hypertens Res 2002; 25: 287–294.
Vogt L, Kocks MJ, Laverman GD, Navis G : Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance? Minerva Med 2004; 95: 395–409.
Stenvinkel P, Andersson P, Wang T, et al: Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure? J Intern Med 1999; 246: 503–507.
Katoh M, Ohmachi Y, Kurosawa Y, Yoneda H, Tanaka N, Narita H : Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice. Eur J Pharmacol 2000; 398: 381–387.
Chen ST, Peng SJ, Chen JR : Effects of dietary protein on renal function and lipid metabolism in five-sixths nephrectomized rats. Br J Nutr 2003; 89: 491–497.
Yang HY, Yang SC, Chen JR, Tzeng YH, Han BC : Soyabean protein hydrolysate prevents the development of hypertension in spontaneously hypertensive rats. Br J Nutr 2004; 92: 507–512.
Hernandez-Ledesma B, Martin-Alvarez PJ, Pueyo E : Assessment of the spectrophotometric method for determination of angiotensin-converting−enzyme activity: influence of the inhibition type. J Agric Food Chem 2003; 51: 4175–4179.
Griesmacher A, Kindhauser M, Andert SE, et al: Enhanced serum levels of thiobarbituric-acid−reactive substances in diabetes mellitus. Am J Med 1995; 98: 469–475.
Aebi H : Catalase in vitro. Methods Enzymol 1984; 105: 121–126.
Marcantoni C, Jafar TH, Oldrizzi L, Levey AS, Maschio G : The role of systemic hypertension in the progression of nondiabetic renal disease. Kidney Int Suppl 2000; 75: S44–S48.
Lebel M, Rodrigue ME, Agharazii M, Lariviere R : Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Am J Hypertens 2006; 19: 1286–1292.
Luno J, Praga M, de Vinuesa SG : The reno-protective effect of the dual blockade of the renin angiotensin system (RAS). Curr Pharm Des 2005; 11: 1291–1300.
Birchem JA, Fraley MA, Senkottaiyan N, Alpert MA : Influence of hypertension on cardiovascular outcomes in hemodialysis patients. Semin Dial 2005; 18: 391–395.
Ferrari P : Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease. Nephrology (Carlton) 2007; 12: 81–89.
Elung-Jensen T, Heisterberg J, Sonne J, Strandgaard S, Kamper AL : Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial. Eur J Clin Pharmacol 2005; 61: 87–96.
Lo WM, Li-Chan EC : Angiotensin I converting enzyme inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein. J Agric Food Chem 2005; 53: 3369–3376.
Chen JR, Okada T, Muramoto K, Suetsuna K, Yang SC : Identification of angiotensin I−converting enzyme inhibitory peptides derived from the peptic digest of soybean protein. J food Biochem 2003; 26: 543–554.
Ahmed A : Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? J Am Geriatr Soc 2002; 50: 1297–1300.
Velasquez MT, Bhathena SJ : Dietary phytoestrogens: a possible role in renal disease protection. Am J Kidney Dis 2001; 37: 1056–1068.
Park E, Shin JI, Park OJ, Kang MH : Soy isoflavone supplementation alleviates oxidative stress and improves systolic blood pressure in male spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 2005; 51: 254–259.
Xu YY, Yang C, Li SN : Effects of genistein on angiotensin-converting enzyme in rats. Life Sci 2006; 79: 828–837.
Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, Lorenzo O, Plaza JJ, Egido J : Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 1998; 161: 430–439.
Klahr S, Morrissey J : Angiotensin II and gene expression in the kidney. Am J Kidney Dis 1998; 31: 171–176.
Ruiz-Ortega M, Esteban V, Ruperez M, et al: Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens 2006; 15: 159–166.
Das UN : Is angiotensin-II an endogenous pro-inflammatory molecule? Med Sci Monit 2005; 11: RA155-RA162.
Gallardo JM, de Carmen Prado-Uribe M, Amato D, Paniagua R : Inflammation and oxidative stress markers by pentoxifylline treatment in rats with chronic renal failure and high sodium intake. Arch Med Res 2007; 38: 34–38.
Alvestrand A : Carbohydrate and insulin metabolism in renal failure. Kidney Int Suppl 1997; 62: S48–S52.
Chen ST, Ferng SH, Yang CS, Peng SJ, Lee HR, Chen JR : Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients. Am J Kidney Dis 2005; 46: 1099–1106.
Noriega-Lopez L, Tovar AR, Gonzalez-Granillo M, et al: Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones. J Biol Chem 2007; 282: 20657–20666.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, HY., Chen, JR. & Chang, LS. Effects of Soy Protein Hydrolysate on Blood Pressure and Angiotensin-Converting Enzyme Activity in Rats with Chronic Renal Failure. Hypertens Res 31, 957–963 (2008). https://doi.org/10.1291/hypres.31.957
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.31.957
Keywords
This article is cited by
-
Biosensor guided effective degradation of anti-nutritional factors via selected soybean fermentation process
Systems Microbiology and Biomanufacturing (2024)
-
Effects of black soy peptide supplementation on blood pressure and oxidative stress: a randomized controlled trial
Hypertension Research (2013)
-
Consumption of krill protein concentrate prevents early renal injury and nephrocalcinosis in female Sprague–Dawley rats
Urological Research (2011)
